What is BioLumic?
BioLumic specializes in the development and deployment of innovative UV light technology that enhances plant vigor and yield. By delivering precise ultraviolet light treatments to seeds and seedlings, the company provides a clean, green, and GM-free alternative to traditional chemical or genetic interventions. This disruptive approach targets the core of agricultural productivity, offering growers a scalable method to improve seed performance and overall crop outcomes. With a focus on both domestic and international markets, including significant operations in South America, BioLumic is positioned at the intersection of biotechnology and precision farming, aiming to revolutionize how the agricultural industry approaches crop management and yield optimization.
How much funding has BioLumic raised?
BioLumic has raised a total of $28.6M across 3 funding rounds:
Series A
$6.7M
Series B
$13.5M
Stock/Share Issuance
$8.3M
Series A (2019): $6.7M with participation from Canopy Rivers, Rabo Food & Agri Innovation Fund, Finistere Ventures, and Radicle Growth Acceleration Fund
Series B (2022): $13.5M led by Icehouse Ventures, OurCrowd, Rabo Ventures, and Finistere Ventures
Stock/Share Issuance (2026): $8.4M, investors not publicly disclosed
Key Investors in BioLumic
Finistere Ventures
Finistere Ventures focuses on investing in individuals and leveraging data to transform large-scale industries, aiming to enhance living, working, and eating experiences through targeted financial strategies.
Icehouse Ventures
Icehouse Ventures is a prominent early-stage venture firm that supports Kiwi innovators, managing a suite of funds with a highly active co-investor network to build world-class companies.
OurCrowd
OurCrowd is a global investment platform based in Israel that provides accredited investors and institutions access to startups, early-stage companies, and venture funds.
What's next for BioLumic?
With the successful closure of this major strategic investment, BioLumic is well-positioned to accelerate its international expansion and deepen its research and development capabilities. The company is expected to focus on scaling its UV technology platform to accommodate a broader range of crop types and environmental conditions. By utilizing this capital, BioLumic will likely enhance its operational infrastructure to meet the increasing demand from large-scale agricultural businesses seeking to integrate sustainable, high-performance solutions into their existing workflows. The strategic focus remains on maintaining a competitive edge through continuous innovation and the expansion of its global footprint, ensuring that its light-based technology becomes a standard tool for modern, efficient, and sustainable farming practices.
See full BioLumic company page
